Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet and suppository dosage form-Reference-Cited by-同舟云学术

Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet and suppository dosage form

Published:2007-03-31 Issue:4 Volume:3 Page:333-342
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

NORLANDER B.,GOTTHARD R.,STRÖM M.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.1989.tb00220.x/fullpdf

Reference16 articles.

1. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid;Klotz;Clin Pharmacokinetics,1985

2. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid;Dew;Br Med J,1982

3. Effect of sulphapyridine, 5-aminosalicylic acid and placebo in patients with idiopathic proctitis: A study to determine the active therapeutic moiety of sulphasalazine;Hees;Gut,1980

4. An experiment to determine the active therapeutic moiety of sulphasalazine;Khan;Lancet,1977

5. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease;Klotz;N Eng J Med,1980

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers;Inflammatory Bowel Diseases;2010-02

2. A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol);Alimentary Pharmacology & Therapeutics;2009-06

3. Steady-state pharmacokinetics of enteric coated 5-amino-salicylic acid tablets in healthy volunteers and in patients with Crohn's disease or ulcerative colitis;Alimentary Pharmacology & Therapeutics;2007-03-31

4. Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteers;Alimentary Pharmacology & Therapeutics;2007-03-31

5. The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: A dose-finding study with newly developed mesalamine;Clinical Gastroenterology and Hepatology;2003-01